The new version of the National Catalogue of Drugs for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance will be implemented in January 2024. The adjustment of the medical insurance catalogue has become a routine once a year, and through medical insurance negotiations, more and more innovative drugs have entered the medical insurance catalogue with appropriate **, and 341 new drugs have entered the medical insurance catalogue with appropriate **, so that patients can use and afford more new drugs and good drugs.
This article will discuss the impact of the adjustment of the medical insurance catalogue on China's pharmaceutical industry, and its role in promoting the innovation, upgrading and development of the pharmaceutical industry.
1. The adjustment of the medical insurance catalogue has promoted the increase in the number of innovative drugs.
Increase the number of new drugs included in the medical insurance list.
Enhance the level of patient benefits and the confidence of innovative drug companies.
2. Adjust the medical insurance catalogue to reduce the economic burden of drug use.
Patients can use and afford more new and good medicines.
Structural adjustment and upgrading of the pharmaceutical industry.
3. The adjustment of the medical insurance catalogue promotes the innovation, upgrading and development of the pharmaceutical industry.
The time cost is greatly reduced, and innovative drugs quickly replace old drugs.
Policy support stimulates the innovation motivation and layout of enterprises.
The adjustment of the medical insurance catalogue not only improves the drug use level of patients and reduces the economic burden, but also promotes the innovation, upgrading and development of the pharmaceutical industry. Through the superposition of medical insurance negotiations and centralized drug procurement policies, China's pharmaceutical market is undergoing structural adjustment, and more and more innovative drugs have entered the market and achieved remarkable results. In the future, the pharmaceutical industry will continue to benefit from the improvement of the medical insurance catalogue and promote the pharmaceutical industry to move towards high-quality development.
In order to further promote the high-quality development of China's pharmaceutical industry, from April 18th to 20th, 2024, the China (Wuxi) Biomedical Industry Expo will be held in the beautiful: Taihu Lake Pearl Jiangnan Shengdi - Wuxi, welcome your visit.